Table 2.
Characteristics and clinical findings at reoperation in the 100 patients with PP
| Variable | Patients with MDR bacteria (n = 41) |
Patients with other bacteria (n = 59) | P |
|---|---|---|---|
| APACHE II, mean ± SD | 21 ± 7 | 21 ± 7 | 0.90 |
| SOFA, mean ± SD | 7 ± 4 | 7 ± 4 | 0.63 |
| ≥ 1 organ failures, n (%) | 32 (78) | 48 (81) | 0.68 |
| Vasopressor support, n (%) | 26 (63) | 41 (69) | 0.38 |
| Time to reoperation (days), mean ± SD | 13 ± 16 | 10 ± 11 | 0.55 |
| Mechanisms of PP | |||
| Anastomotic leakage, n (%) | 14 (34) | 20 (34) | 0.98 |
| Perforation, n (%) | 9 (22) | 21 (36) | 0.14 |
| Miscellaneous, n (%) | 8 (20) | 10 (17) | 0.98 |
| Unknown cause, n (%) | 10 (24) | 8 (14) | 0.27 |
| Source of PP | |||
| Lower intestinal tract, n (%) | 16 (39) | 32 (54) | 0.67 |
APACHE, acute physiology and chronic health evaluation; MDR, multidrug resistant; PP, postoperative peritonitis; SD, standard deviation; SOFA, Sequential Organ Failure Assessment.